Authors: | Feldman, D. R.; Hu, J. S.; Patil, S.; Reuter, V. E.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Milowsky, M. I.; Appleman, L. J.; Dorff, T. B.; Bromberg, M.; Joseph, G.; Funt, S. A.; Bajorin, D. F.; Bosl, G. J.; Quinn, D. I.; Motzer, R. J. |
Abstract Title: | Biomarkers of outcomes in a randomized phase II trial of first-line paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for intermediate- and poor-risk germ cell tumors (GCT) |
Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
Journal Title: | Journal of Clinical Oncology |
Volume: | 37 |
Issue: | 15 Suppl. |
Meeting Dates: | 2019 May 31-Jun 4 |
Meeting Location: | Chicago, IL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2019-05-20 |
Start Page: | 279s |
Language: | English |
ACCESSION: | WOS:000487345805385 |
DOI: | 10.1200/JCO.2019.37.15_suppl.4563 |
PROVIDER: | wos |
Notes: | Meeting Abstract: 4563 -- Source: Wos |